<!doctype html><html class=no-js lang=en><head><meta charset=UTF-8><meta name=viewport content="width=device-width,initial-scale=1"><title>ç§‘ç ”æ—¥æŠ¥ 2026-01-24 - ç”Ÿä¿¡æ™®æ‹‰æ–¯</title>
<script>(function(e,t){e[t]=e[t].replace("no-js","js")})(document.documentElement,"className")</script><meta name=description content><meta property="og:url" content="https://ixxmu.github.io/posts/dailyreports/2026-01-24/"><meta property="og:site_name" content="ç”Ÿä¿¡æ™®æ‹‰æ–¯"><meta property="og:title" content="ç§‘ç ”æ—¥æŠ¥ 2026-01-24"><meta property="og:description" content="ğŸ“… Daily Report - 2026-01-24 ä»Šæ—¥ç­›é€‰å‡º 41 æ¡å†…å®¹ï¼Œæ¥è‡ª 2 ä¸ªæ¥æº"><meta property="og:locale" content="zh_cn"><meta property="og:type" content="article"><meta property="article:section" content="posts"><meta property="article:published_time" content="2026-01-24T00:00:00+00:00"><meta property="article:modified_time" content="2026-01-24T00:00:00+00:00"><meta property="article:tag" content="Research"><meta property="article:tag" content="Daily"><meta property="article:tag" content="Week042026"><meta itemprop=name content="ç§‘ç ”æ—¥æŠ¥ 2026-01-24"><meta itemprop=description content="ğŸ“… Daily Report - 2026-01-24 ä»Šæ—¥ç­›é€‰å‡º 41 æ¡å†…å®¹ï¼Œæ¥è‡ª 2 ä¸ªæ¥æº"><meta itemprop=datePublished content="2026-01-24T00:00:00+00:00"><meta itemprop=dateModified content="2026-01-24T00:00:00+00:00"><meta itemprop=wordCount content="2257"><meta itemprop=keywords content="Research,Daily,Week042026"><meta name=twitter:card content="summary"><meta name=twitter:title content="ç§‘ç ”æ—¥æŠ¥ 2026-01-24"><meta name=twitter:description content="ğŸ“… Daily Report - 2026-01-24 ä»Šæ—¥ç­›é€‰å‡º 41 æ¡å†…å®¹ï¼Œæ¥è‡ª 2 ä¸ªæ¥æº"><link rel=preconnect href=https://fonts.gstatic.com crossorigin><link rel=dns-prefetch href=//fonts.googleapis.com><link rel=dns-prefetch href=//fonts.gstatic.com><link rel=stylesheet href="https://fonts.googleapis.com/css?family=Open+Sans:400,400i,700"><link rel=stylesheet href=../../../css/style.css><link rel=stylesheet href=../../../css/custom.css><link rel="shortcut icon" href=../../../favicon.ico></head><body class=body><div class="container container--outer"><header class=header><div class="container header__container"><div class=logo><a class=logo__link href=../../../ title=ç”Ÿä¿¡æ™®æ‹‰æ–¯ rel=home><div class="logo__item logo__text"><div class=logo__title>ç”Ÿä¿¡æ™®æ‹‰æ–¯</div><div class=logo__tagline>è¿‘åå¹´æœ€å€¼å¾—ä¸Šæ‰‹çš„ç”Ÿç‰©åŒ»å­¦ç”Ÿä¿¡ä»£ç </div></div></a></div><nav class=menu><button class=menu__btn aria-haspopup=true aria-expanded=false tabindex=0>
<span class=menu__btn-title tabindex=-1>Menu</span></button><ul class=menu__list><li class=menu__item><a class=menu__link href=../../../posts/><span class=menu__text>æ–‡ç« </span></a></li><li class=menu__item><a class=menu__link href=../../../tags/><span class=menu__text>æ ‡ç­¾</span></a></li><li class=menu__item><a class=menu__link href=../../../about/><span class=menu__text>å…³äº</span></a></li></ul></nav></div></header><div class="wrapper flex"><div class=primary><main class=main role=main><article class=post><header class=post__header><meta name=referrer content="never"><h1 class=post__title>ç§‘ç ”æ—¥æŠ¥ 2026-01-24</h1><div class="post__meta meta"><div class="meta__item-datetime meta__item"><svg class="meta__icon icon icon-time" width="16" height="14" viewBox="0 0 30 28"><path d="M15 0a14 14 0 110 28 1 1 0 010-28m0 3a3 3 0 100 22 3 3 0 000-22m1 4h-2v8.4l6.8 4.4L22 18l-6-3.8z"/></svg><time class=meta__text datetime=2026-01-24T00:00:00Z>2026-01-24</time></div><div class="meta__item-categories meta__item"><svg class="meta__icon icon icon-category" width="16" height="16" viewBox="0 0 16 16"><path d="m7 2 1 2h8v11H0V2z"/></svg><span class=meta__text><a class=meta__link href=../../../categories/dailyreport/ rel=category>DailyReport</a></span></div><div class="meta__item-author meta__item"><svg class="meta__icon icon icon-author" width="16" height="16" viewBox="0 0 16 16"><path d="M8 1c2 0 3.5 2 3.5 4.5S10 9 10 9c3 1 4 2 4 6H2c0-4 1-5 4-6 0 0-1.5-1-1.5-3.5S6 1 8 1"/></svg><span class=meta__text>Bloger</span></div></div></header><div class="post__toc toc"><div class=toc__title>Page content</div><div class=toc__menu><nav id=TableOfContents><ul><li><a href=#-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</a><ul><li><a href=#-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</a></li><li><a href=#-åšå®¢æ›´æ–°>ğŸ§ª åšå®¢æ›´æ–°</a></li></ul></li><li><a href=#-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</a><ul><li></li></ul></li><li><a href=#-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</a></li><li><a href=#-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</a></li></ul></nav></div></div><div class="content post__content clearfix"><h1 id=-daily-report---2026-01-24>ğŸ“… Daily Report - 2026-01-24</h1><blockquote><p>ä»Šæ—¥ç­›é€‰å‡º <strong>41</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>2</strong> ä¸ªæ¥æº</p></blockquote><div class=powered-by-top>Powered by <a href=https://kyplus.de>ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href=https://claude.ai>Claude</a></div><hr><h2 id=-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2><h3 id=-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
æ–°å‹å•ç»†èƒæµ‹åºæ–¹æ³•RoCK and ROI å¢å¼ºè½¬å½•ç»„ä¿¡æ¯è·å–ï¼›ç©ºé—´ç»„å­¦æŠ€æœ¯Seq-Scope-Xçªç ´å…‰å­¦åˆ†è¾¨ç‡é™åˆ¶ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li><strong>ç–¾ç—…æœºåˆ¶æ¢ç´¢</strong>ï¼šèšç„¦ç³–å°¿ç—…è‚¾ç—…ã€é˜¿å°”èŒ¨æµ·é»˜ç—…ã€COVID-19ã€çš®è‚¤ç™Œã€å°ç»†èƒè‚ºç™Œã€è‘¡è„è†œé»‘è‰²ç˜¤è‚è½¬ç§»ã€ç™«ç—«ç­‰ç–¾ç—…çš„å…³é”®è°ƒæ§å› å­ä¸å¾®ç¯å¢ƒé‡å¡‘ã€‚</li><li><strong>å…ç–«ç»†èƒåŠŸèƒ½è°ƒæ§</strong>ï¼šæ·±å…¥ç ”ç©¶CAR-Tç»†èƒåŠŸèƒ½ã€æ·‹å·´ç»†èƒé€‚åº”æ€§ç¼–ç¨‹ã€å•æ ¸ç»†èƒè¡¨å‹ä¸å…ç–«è®°å¿†å½¢æˆã€‚</li><li><strong>ä»£è°¢ä¸è¡¨è§‚é—ä¼ </strong>ï¼šé˜æ˜èƒ†å›ºé†‡ä»£è°¢ã€Î²ç»†èƒåŠŸèƒ½ã€èƒ½é‡æ„ŸçŸ¥åˆ†å­åœ¨ç–¾ç—…ä¸­çš„ä½œç”¨ï¼Œä»¥åŠä»£è°¢å¯¹è¡¨è§‚é—ä¼ çš„é‡å¡‘ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li><strong>å•ç»†èƒå¤šç»„å­¦</strong>ï¼šç»“åˆscRNA-seqä¸scATAC-seqç­‰æŠ€æœ¯ï¼Œè§£æç»†èƒå¼‚è´¨æ€§ä¸åŸºå› è°ƒæ§ã€‚</li><li><strong>ç©ºé—´ç»„å­¦</strong>ï¼šå¼€å‘Seq-Scope-Xç­‰æŠ€æœ¯ï¼Œå®ç°é«˜åˆ†è¾¨ç‡çš„ç©ºé—´è½¬å½•ç»„åˆ†æã€‚</li></ul><h3 id=-åšå®¢æ›´æ–°>ğŸ§ª åšå®¢æ›´æ–°</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
æ–°å‹æŠ—ä½“æœ‰æœ›æ”»å…‹ä¸‰é˜´æ€§ä¹³è…ºç™Œï¼Œé•¿è¯»é•¿RNAæµ‹åºæŠ€æœ¯åœ¨æ—å¥‡ç»¼åˆå¾è¯Šæ–­æ–¹é¢å–å¾—çªç ´ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>é’ˆå¯¹ä¸‰é˜´æ€§ä¹³è…ºç™Œçš„é¶å‘æ²»ç–—ç ”ç©¶</li><li>åˆ©ç”¨é•¿è¯»é•¿RNAæµ‹åºæŠ€æœ¯æ”¹è¿›æ—å¥‡ç»¼åˆå¾çš„åŸºå› è¯Šæ–­</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>å‘ç°å¹¶éªŒè¯å¯é¶å‘è‚¿ç˜¤ç”Ÿé•¿ç›¸å…³è›‹ç™½çš„æ–°å‹å®éªŒæ€§æŠ—ä½“</li><li>åº”ç”¨é¶å‘é•¿è¯»é•¿RNAæµ‹åºæŠ€æœ¯ï¼Œæœ‰æ•ˆè¯†åˆ«è‡´ç—…æ€§å‰ªæ¥ç¼ºé™·ï¼Œå¹¶è§£å†³æ—å¥‡ç»¼åˆå¾ä¸­çš„ä¸ç¡®å®šå˜å¼‚ã€‚</li></ul><hr><h2 id=-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</h2><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§¬ æ•°æ®å‰æ²¿ (39æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å‰10æ¡>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4><p><strong>1.</strong> â­ <strong>GSE287840 RoCK å’Œ ROIï¼šä¸€ç§é€šè¿‡é¶å‘å¯Œé›†è½¬å½•æœ¬å’Œé¢„é€‰åŒºåŸŸç‰¹å¼‚æ€§æµ‹åºå¢å¼ºè½¬å½•ç»„ä¿¡æ¯çš„å•ç»†èƒ RNA æµ‹åºæ–¹æ³• IV</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsequencingã€single-cellã€transcriptomeã€enrichment</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Giulia Moro ; Izaskun Mallona ; Malwine J Barz ; Lorenz Bastian ; Claudia D Baldus ; Mark D Robinson ; Erich Brunner ; Konrad BaslerSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensMany scRNAseq-based methods suffer from a high number of non-detects and a bias towards the 3&rsquo; or 5&rsquo; end of transcripts. We developed a method termed RoCK and ROI to address these two biases. RoCK and ROI leads to the enrichment of the transcriptome profile of cells with information on transcripts of interest</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287840">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> â­ <strong>GSE317266 èƒ½é‡æ„ŸçŸ¥åˆ†å­RORÎ³åœ¨ç³–å°¿ç—…è‚¾ç—…å’Œè¡°è€è¿‡ç¨‹ä¸­è°ƒèŠ‚èƒ†å›ºé†‡ä»£è°¢å’Œå…ç–«ä¿¡å·ä¼ å¯¼</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€agingã€metabolism</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensAging is a major risk factor for diabetic kidney disease (DKD), with both conditions exhibiting similar renal pathology. We identify the energy-sensing molecule Retinoic acid-related orphan receptor Î³ (RORÎ³) as significantly downregulated in diabetic and aged kidneys. Tubule-specific RORÎ³ deficiency exacerbates kidney injury, whereas its overexpression protects. Mechanistically, RORÎ³ stabilizes insulin-induced gene 1 (INSIG1) by upregulating the deubiquitinase YOD1 and enhancing AMPK activity via CAB39, which together promote INSIG1 phosphorylation and subsequent stabilization. Stabilized INSIG1 potently blocks the ER-to-Golgi transport and activation of SREBP2 (cholesterol synthesis) and STING (inflammatory signaling). In diabetes, RORÎ³ itself is suppressed transcriptionally by CTCF and functionally by impaired AMPK/SIRT1 signaling, which hinders its activation. Importantly, administration of a RORÎ³ agonist or RORÎ³-enriched exosomes effectively alleviates diabetic kidney injury. Thus, RORÎ³ emerges as a key regulatory node that mitigates DKD and renal aging by co-regulating AMPK-mediated metabolic and STING-driven innate immune pathways through INSIG1 stabilization.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317266">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> â­ <strong>GSE297529 åˆ©ç”¨å•ç»†èƒå¤šç»„å­¦æµ‹åºå‘ç°ä¸ COVID-19 ä¸¥é‡ç¨‹åº¦ç›¸å…³çš„ç»å…¸å•æ ¸ç»†èƒè¡¨å‹ä¸­çš„å…³é”®è°ƒæ§å› å­</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šmonocyteã€sequencingã€single-cell</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Donggun Kim ; Sin Young Choi ; Eui Tae Kim ; Jihwan ParkSeries Type : Expression profiling by high throughput sequencing ; Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensDysregulated immune responses often accompany severe COVID-19, but the underlying epigenetic mechanisms driving monocyte heterogeneity and disease progression remain poorly understood. Here, we applied single-cell multi-omics profiling to peripheral blood mononuclear cells from individuals across five COVID-19 severity stages. We identified two severity-associated classical monocyte subtypes-IL7R+ and CD163+-characterized by distinct transcriptional and epigenetic landscapes. Using constructing of gene regulatory network and in silico TF perturbations, we revealed ETS1 as a key driver of IL7R+ monocytes with T cell-like signaling features, and JDP2 as a repressor maintaining the pro-fibrotic, anti-inflammatory identity of CD163+ monocytes via suppression of AP-1 activity. These subtypes were enriched in moderate-to-critical stages and exhibited signaling pathways associated with tissue remodeling and immune suppression. Our findings define monocyte heterogeneity linked to COVID-19 severity and identify ETS1 and JDP2 as central regulators, offering insight into immune dysregulation and potential therapeutic targets for fibrosis and long-term sequelae.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297529">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> â­ <strong>GSE275131 æŠ‘åˆ¶ç¡¬è„‚é…°è¾…é…¶Aå»é¥±å’Œé…¶ï¼ˆSCDï¼‰å¯¹é˜¿å°”èŒ¨æµ·é»˜ç—…ï¼ˆADï¼‰å°é¼ æ¨¡å‹ç©ºé—´è½¬å½•ç»„çš„å½±å“</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šAlzheimerã€spatialã€transcriptome</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Audrey Hector ; BenoÃ®t Delignat-Lavaud ; Valerie MongrainSeries Type : OtherOrganism : Mus musculusHere, the effects of a stearoyl-CoA desaturase inhibitor (SCDi) on the mouse brain spatial transcriptome was investigated. More precisely, wild-type and 3xTg-AD female mice were infused in the brain left lateral ventricle with control (DMSO) or SCDi during 28 days (after the implantation of electrodes for electrocorticography and electromyography). Brains were sampled on the morning of Day 31 after the beginning of treatment, and immediately frozen. Brains were treated and libraries were prepared according to 10x Genomics protocols for Visium Spatial Gene Expression. Sequencing was conducted by Genome Quebec (Montreal, QC, Canada).</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE275131">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>5.</strong> â­ <strong>GSE287857 LDHA é€šè¿‡ä»£è°¢è¡¨è§‚é—ä¼ é‡ç¼–ç¨‹è¯±å¯¼ç³–å°¿ç—…ä¸­çš„ Î² ç»†èƒå»åˆ†åŒ– [RNA-Seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šmetabolicã€RNA-seqã€epigenetic</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Xirui Li ; Haoqiang Gong ; Can Xiong ; Xinyue Huang ; Mei He ; Liangjun Sun ; Wenyue Yin ; Suyun Zou ; Min Sha ; Wanhua Guo ; Tijun Wu ; Qingguo Li ; Yaqin Zhang ; Fang ChenSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusAims/hypothesis Pancreatic Î² cell dedifferentiation underlies the reversible reduction in Î² cell mass and function in diabetes. Interventional targets and adjuvant therapies to prevent/reverse Î² cell dedifferentiation and transdifferentiation may provide evidence to support the effective treatment of diabetes, while the underlying molecular mechanism remains elusive. Methods LDHA expression and activity were analysed in islets obtained from humans with type 2 diabetes, hyperglycaemic db/db mice, and a high-fat diet (HFD)-induced mouse model of diabetes. The impact of LDHA inhibition on Î² cell function and identity was investigated in high-fat diet (HFD) feeding mice and db/db mice. ChIP-seq and RNA-seq were used to investigate the specific molecular mechanism underlying the effect of LDHA on the H3K9la enhancement and beta cell function under glucotoxic conditions. Results We demonstrated that inhibition of LDHA effectively preserved Î² cell identity, which not only delay disease progression in prediabetic stage, but also improve insulin output and glucose homeostasis in diabetic models. Mechanistically, the activation of LDHA led to a marked increase in histone H3 lysine 9 lactylation (H3K9la) in the promoter region of the Î² cells dedifferentiation markers Sox9, Hes1 and Aldh1a3, and facilitated their transcription, thereby triggering Î² cell dedifferentiation as well as impaired glucose homeostasis and Î² cell function in mice. Conclusions/interpretation We unraveled the role of lactate dehydrogenase A (LDHA)-mediated metabolic and epigenetic reprogramming in Î² cell dedifferentiation during diabetes development. This study suggests that LDHA inhibition could be a novel therapeutic strategy for diabetes treatment.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287857">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>6.</strong> â­ <strong>GSE284026 NR2F6 ç¼ºå¤±å¯æ¢å¤ CAR-T ç»†èƒåŠŸèƒ½å¹¶è¯±å¯¼å®ä½“ç˜¤ä¸­æŠ—åŸéç‰¹å¼‚æ€§å…ç–«è®°å¿†</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€T cellã€antigen</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Dominik Humer ; Victoria Klepsch ; Dietmar Rieder ; Gottfried BaierSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusCARâ€‘T cell therapy is effective in hematologic malignancies but remains challenging in solid tumors owing to antigen heterogeneity and tumor microenvironmentâ€‘induced exhaustion. Here, gene editing of the nuclear receptor NR2F6 restores CARâ€‘T cell functionality, sustaining a TCF1âº progenitorâ€‘exhausted T cell phenotype, enhancing metabolic fitness, and preserving cytotoxic potency under chronic antigen exposure. In immunocompetent models, Nr2f6â€‘deficient CARâ€‘T cells suppress solid tumor growth and induce robust, polyclonal host antitumor responses, as shown by protection in tumor reâ€‘challenge experiments. Although infused CARâ€‘T cells disappear within 2 weeks, durable tumor control coincides with epitope spreading and secondary immune responses, likely via dendritic and other antigenâ€‘presenting cell reactivation. Protection against antigenâ€‘negative tumors and transferable immunity reveal a dual mode of direct cytotoxicity followed by durable immune reprogramming. This broadened host immunity may offset immune escape driven by antigen loss and tumor heterogeneity, establishing NR2F6 inhibition as a promising CARâ€‘T engineering strategy for durable, antigenâ€‘agnostic solidâ€‘tumor immunotherapy.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE284026">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>7.</strong> <strong>GSE308414 é€æ­¥è¡¨è§‚é—ä¼ ä¿¡å·æ•´åˆæ§åˆ¶ç»†èƒæ¯’æ€§æ·‹å·´ç»†èƒçš„é€‚åº”æ€§ç¼–ç¨‹ [ATAC-seq AP1æŠ‘åˆ¶å‰‚]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šATAC-seqã€epigenetic</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Simon Grassmann ; Hyunu Kim ; Joseph SunSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Mus musculusLymphocyte differentiation depends on activation via antigen and cytokines during the immune response to infection. How the timing and integration of these signals program the epigenetic and functional fate of these cells is not completely understood. In this study, we find that inflammatory cytokine signals received by innate and adaptive lymphocytes have a context-dependent role for immune memory formation. Without preceding and sufficient antigen receptor signaling, inflammatory cytokines drive terminal differentiation into short-lived effector cells. In contrast, sufficient antigen-receptor signaling redirects inflammatory cytokine signals to promote memory differentiation via cooperation of STAT and AP-1 transcription factors. By this crucial epigenetic mechanism, optimally equipped lymphocytes are selected for memory formation rather than a terminal effector cell fate. Whereas T cells are hardwired to be shielded from premature inflammatory signals, NK cells rely on coincidental early antigen receptor signaling for adaptive responses. Together, step-wise integration of antigen and cytokine signaling optimizes both effector and memory differentiation, allowing for promiscuous recruitment into the acute immune response while promoting avidity maturation in memory populations of both innate and adaptive lymphocytes.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308414">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>8.</strong> <strong>GSE304036 éä¾µå…¥æ€§è¡¨çš®å–æ ·ç”¨äºåŸºäºDNAç”²åŸºåŒ–çš„çš®è‚¤ç™Œè¡¨å‹é¢„æµ‹</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€methylation</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Manuel RodrÃ­guez-Paredes ; Yan Feng ; Oliver Gilliam ; Katrin Wegner ; GÃ¼nter Raddatz ; Elke GrÃ¶nniger ; Frank LykoSeries Type : Methylation profiling by genome tiling arrayOrganism : Homo sapiensThe epidermis is uniquely exposed to the effects of environmental factors such as ultraviolet radiation, which induce progressive genetic and epigenetic modifications contributing to aging and the onset of keratinocyte carcinomas. DNA methylation is the best-characterized epigenetic modification and a valuable biomarker for assessing epidermal health. However, broad screening approaches have been hindered by the limited quantity and quality of the genomic DNA obtained from the epidermis and the resulting need for invasive sampling methods. Here we describe an integrated method that enables the non-invasive sampling of epidermal DNA for subsequent analysis by DNA methylation microarrays. This procedure combines a gel-based adhesive tape for keratinocyte collection, a robust gDNA extraction protocol and a curated selection of microarray probes optimized for low-input DNA conditions. Analysis of >100 corresponding methylomes demonstrates that our approach can be used for both the training of epigenetic clocks capable of predicting epidermal age with high accuracy, as well as the investigation of various DNA methylation-based biomarkers relevant to keratinocyte cancer development. These findings underscore the potential of our method for broad and non-invasive skin health assessment and cancer prevention strategies.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304036">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>9.</strong> <strong>GSE316934 é«˜è„‚é¥®é£Ÿåé‡ç”Ÿå‹å’ŒCamk2dé«“ç³»æ¡ä»¶æ€§æ•²é™¤å°é¼ eWATåŸºè´¨è¡€ç®¡ç»„åˆ†ç»†èƒçš„å•ç»†èƒRNAæµ‹åº</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šRNA-seqã€single-cell</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Yifan Tu ; Ke Sui ; Zheng Wang ; Jiawei Zhang ; Ying GuSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusEpididymal white adipose tissue (eWAT) stromal vascular fraction (SVF) cells were profiled by 10x Genomics Chromium Single Cell 3â€² v1 scRNA-seq to characterize immune-cell states in diet-induced obesity. SVF cells were isolated by collagenase digestion, filtered, and processed when viability exceeded 85%. Libraries were sequenced on an Illumina NovaSeq 6000 (PE150). Reads were aligned to mm10 and geneâ€“cell count matrices were generated with Cell Ranger count v5.0.0 and aggregated across samples with Cell Ranger aggr. Downstream analyses were performed in Seurat v4.1.1 with QC filtering, ambient RNA correction (SoupX v1.3.0), doublet detection (DoubletFinder v2.0.2), batch correction (fastMNN), clustering/UMAP, and differential expression testing (MAST). Cell types were annotated using SingleR v1.4.1 and canonical markers; non-immune cells were excluded for immune-focused analyses. Additional analyses included pseudotime inference (Monocle2 v2.14.0) and cellâ€“cell communication analysis (CellChat v0.0.2).</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316934">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>10.</strong> <strong>GSE287891 è½¬å½•å› å­ Traffic jam åè°ƒæœè‡åµå·¢ä¸­çš„ä½“ç»†èƒ piRNA é€šè·¯ [RNA-seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šRNA-seqã€pathway</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Azad Alizada ; Aline Martins ; Nolwenn MouniÃ©e ; Julia V Rodriguez Suarez ; Benjamin Bertin ; Nathalie Gueguen ; Vincent Mirouse ; Anna-Maria Papameletiou ; Austin J Rivera ; Nelson C Lau ; Abdou Akkouche ; StÃ©phanie Maupetit-Mehouas ; Gregory J Hannon ; Benjamin Czech Nicholson ; Emilie BrassetSeries Type : Expression profiling by high throughput sequencingOrganism : Drosophila melanogasterThe PIWI-interacting RNA (piRNA) pathway is essential for transposable element (TE) silencing in animal gonads. While the transcriptional regulation of piRNA pathway components in germ cells has been documented in mice and flies, their control in somatic cells of Drosophila ovaries remains unresolved. Here, we demonstrate that Traffic jam (Tj), the Drosophila orthologue of large Maf transcription factors in mammals, is a master regulator of the somatic piRNA pathway. Tj binds to regulatory regions of somatic piRNA factors and the major piRNA cluster flamenco, which carries a Tj-bound enhancer downstream of its promoter. Depletion of Tj in somatic follicle cells causes downregulation of piRNA factors, loss of flam expression and de-repression of gypsy-family TEs. We propose that the arms race between the host and TEs led to the co-evolution of promoters in piRNA pathway genes as well as TE regulatory regions that both rely on a shared transcription factor.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287891">æŸ¥çœ‹åŸæ–‡</a></li></ul><blockquote><p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 29 æ¡å†…å®¹ï¼Œè¯¦è§ <a href=#%E6%9B%B4%E5%A4%9A-%E6%95%B0%E6%8D%AE%E5%89%8D%E6%B2%BF>æ–‡æœ«</a></p></blockquote></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§ª åšå®¢æ›´æ–° (2æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å…¨éƒ¨2æ¡>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨2æ¡ï¼‰</h4><p><strong>1.</strong> <strong>é¶å‘é•¿è¯»é•¿RNAæµ‹åºæé«˜äº†æ—å¥‡ç»¼åˆå¾çš„è¯Šæ–­ç‡ã€‚</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsequencing</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šTargeted long-read RNA sequencing reveals pathogenic splicing defects and resolves uncertain variants in Lynch syndrome, highlighting the clinical value of transcript-level analysis&mldr;</li><li>ğŸ”— <a href=https://www.rna-seqblog.com/targeted-long-read-rna-sequencing-improves-diagnosis-of-lynch-syndrome/>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> <strong>è¿™ç§æ–°å‹æŠ—ä½“æˆ–è®¸èƒ½å¤Ÿé˜»æ­¢æœ€è‡´å‘½çš„ä¹³è…ºç™Œä¹‹ä¸€çš„å‘ç”Ÿã€‚</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šantibody</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šResearchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of the disease. An experimental antibody targets a protein that fuels tumor growth and shuts down immune defenses, effectively turning the immune system back on. In early tests, the treatment slowed tumor growth, reduced lung metastases, and destroyed chemotherapy-resistant cancer cells.</li><li>ğŸ”— <a href=https://www.sciencedaily.com/releases/2026/01/260122074030.htm>æŸ¥çœ‹åŸæ–‡</a></li></ul></div></details><h2 id=-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2><table><thead><tr><th>å…³é”®è¯</th><th>å‡ºç°æ¬¡æ•°</th></tr></thead><tbody><tr><td>RNA-seq</td><td>8</td></tr><tr><td>cancer</td><td>6</td></tr><tr><td>ATAC-seq</td><td>4</td></tr><tr><td>epigenetic</td><td>4</td></tr><tr><td>transcriptome</td><td>4</td></tr><tr><td>sequencing</td><td>3</td></tr><tr><td>methylation</td><td>3</td></tr><tr><td>single-cell</td><td>3</td></tr><tr><td>scRNA</td><td>3</td></tr><tr><td>immune</td><td>2</td></tr><tr><td>aging</td><td>2</td></tr><tr><td>metabolism</td><td>2</td></tr><tr><td>spatial</td><td>2</td></tr><tr><td>genome</td><td>2</td></tr><tr><td>metabolic</td><td>2</td></tr><tr><td>monocyte</td><td>1</td></tr><tr><td>TME</td><td>1</td></tr><tr><td>Alzheimer</td><td>1</td></tr><tr><td>scATAC</td><td>1</td></tr><tr><td>regex:intestin(e</td><td>al)</td></tr></tbody></table><hr><h2 id=-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</h2><details><summary><a name=æ›´å¤š-æ•°æ®å‰æ²¿></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (29æ¡)</summary><div class=details-content markdown=1><ul><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287858">GSE287858 LDHAé€šè¿‡ä»£è°¢è¡¨è§‚é—ä¼ é‡ç¼–ç¨‹è¯±å¯¼ç³–å°¿ç—…Î²ç»†èƒå»åˆ†åŒ–</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287823">GSE287823 ä¸¤ç§è·å¾—æ€§ç™«ç—«å¤§é¼ æ¨¡å‹ä¸­åŸºå› è¡¨è¾¾å’Œç”²åŸºåŒ–å˜åŒ–çš„å…±æ€§ [RNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317298">GSE317298 å¤šç»„å­¦åˆ†ææ­ç¤ºå¾®ç¯å¢ƒé‡å¡‘æ˜¯å±‹å°˜è¨è¯±å‘è‚ºç™Œè¿›å±•çš„å…³é”®é©±åŠ¨å› ç´ </a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309245">GSE309245 é€æ­¥ä¿¡å·æ•´åˆæ§åˆ¶æ·‹å·´ç»†èƒçš„é€‚åº”æ€§ç¼–ç¨‹ [bulkRNA-seq å’Œ ATAC-seq 6 å°æ—¶åˆºæ¿€]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308415">GSE308415 é€æ­¥è¡¨è§‚é—ä¼ ä¿¡å·æ•´åˆæ§åˆ¶ç»†èƒæ¯’æ€§æ·‹å·´ç»†èƒçš„é€‚åº”æ€§ç¼–ç¨‹ [CUT&amp;RUN STAT1 STAT5 cJun]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294461">GSE294461 æ¯”è¾ƒä¸¤ç§ä¸åŒç±»å‹è‚¿ç˜¤ï¼ˆB16/F10-BrM å’Œ H2030-BrMï¼‰è„‘è‚¿ç˜¤å¾®ç¯å¢ƒä¸­çš„ CD74+ ä¸ CD74- å°èƒ¶è´¨ç»†èƒ/å·¨å™¬ç»†èƒ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292377">GSE292377 é€æ­¥ä¿¡å·æ•´åˆæ§åˆ¶æ·‹å·´ç»†èƒçš„é€‚åº”æ€§ç¼–ç¨‹ [bulkRNA-seq å’Œ ATAC-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292296">GSE292296 é€æ­¥ä¿¡å·æ•´åˆæ§åˆ¶æ·‹å·´ç»†èƒçš„é€‚åº”æ€§ç¼–ç¨‹ [scRNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317349">GSE317349 GDF15 é‡ç¼–ç¨‹å¾®ç¯å¢ƒä»¥é©±åŠ¨è‘¡è„è†œé»‘è‰²ç´ ç˜¤è‚è½¬ç§»çš„å‘å±• [scRNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317347">GSE317347 GDF15 é‡ç¼–ç¨‹å¾®ç¯å¢ƒä»¥é©±åŠ¨è‘¡è„è†œé»‘è‰²ç´ ç˜¤è‚è½¬ç§»çš„å‘å±• [bulk RNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316978">GSE316978 ç±³ç´¢éœ‰ç´ æ”¹å˜ EWS::FLI1 DNA ç»“åˆå’Œ RNA èšåˆé…¶ II åŠ å·¥èƒ½åŠ›ä»¥æŠ‘åˆ¶æ–°ç”Ÿè½¬å½• [RNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316811">GSE316811 Seq-Scope-eXpanded (Seq-Scope-X): è¶…è¶Šå…‰å­¦åˆ†è¾¨ç‡çš„ç©ºé—´ç»„å­¦</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303770">GSE303770 ISL1ï¼šå°ç»†èƒè‚ºç™Œä¸­ä¸€ç§æ–°å‹ç¥ç»å†…åˆ†æ³Œäºšå‹é¢„æµ‹å¯¹é²æ¯”æ›¿å®šçš„æŒä¹…ååº”</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298610">GSE298610 ç»å…¸ BAF å¤åˆç‰©é€šè¿‡è¾…å› å­å¼•å¯¼çš„æŸ“è‰²è´¨é‡å¡‘æ¥è°ƒæ§é—´å……è´¨å¹²ç»†èƒå¾®ç¯å¢ƒç»„æˆå’Œå‘½è¿ [RNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298609">GSE298609 ç»å…¸ BAF å¤åˆç‰©é€šè¿‡è¾…å› å­å¼•å¯¼çš„æŸ“è‰²è´¨é‡å¡‘æ¥è°ƒæ§é—´å……è´¨å¹²ç»†èƒå¾®ç¯å¢ƒç»„æˆå’Œå‘½è¿ [scATAC-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298608">GSE298608 ç»å…¸ BAF å¤åˆç‰©é€šè¿‡è¾…å› å­å¼•å¯¼çš„æŸ“è‰²è´¨é‡å¡‘æ¥è°ƒæ§é—´å……è´¨å¹²ç»†èƒå¾®ç¯å¢ƒç»„æˆå’Œå‘½è¿ [scRNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281433">GSE281433 è´ç‰¹ç±»è¯ç‰©è‹¯æ‰è´ç‰¹å¯¹è…¹æ°´ä»‹å¯¼çš„ä¸Šçš®ç™Œç»†èƒè½¬å½•å˜åŒ–çš„å½±å“</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281415">GSE281415 åµå·¢ç™Œè…¹æ°´æš´éœ²å¯¹ä¸Šçš®ç™Œç»†èƒç³»çš„å½±å“</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317332">GSE317332 ç”¨äºæ¢æµ‹äººç±» iPSC è¡ç”Ÿè‚ é“ç±»å™¨å®˜å¯¹åŸºè´¨ä¿¡å·çš„è½¬å½•ååº”çš„å®Œæ•´å®šä¹‰æ–¹æ¡ˆå’ŒåŸºäº PEG çš„å¹³å°</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315629">GSE315629 å…¨åŸºå› ç»„é‰´å®š 786-O ç»†èƒä¸­ H4K12 ä¹³é…¸åŒ–å’Œ GR çš„è½¬å½•é¶ç‚¹ï¼ˆæ— è®ºæ˜¯å¦ç”¨åœ°å¡ç±³æ¾å¤„ç†ï¼‰ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315326">GSE315326 å…¨åŸºå› ç»„é‰´å®šé€æ˜ç»†èƒè‚¾ç»†èƒç™Œ (ccRCC) ç»†èƒä¸­ H4K12 ä¹³é…¸åŒ–çš„è½¬å½•é¶ç‚¹</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314501">GSE314501 Mettl18ç¼ºé™·èƒšèƒçš„ç»¼åˆè½¬å½•ç»„åˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308156">GSE308156 CARM1ä»‹å¯¼çš„å¯Œå«æ¬¡é»„å˜Œå‘¤çš„å¤–æ³Œä½“ç”Ÿç‰©åˆæˆé‡å¡‘CD8+ Tç»†èƒçš„è‚Œè‹·ä»£è°¢å¹¶å‰Šå¼±å…¶æŠ—è‚¿ç˜¤èƒ½åŠ›</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306334">GSE306334 é¶å‘KEAP1å¤±æ´»è‚ºç™Œä¸­çš„æ³›ç´ ä¿¡å·é€šè·¯è„†å¼±æ€§</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289768">GSE289768 è¡°è€é€šè¿‡æ¿€æ´»æ•´åˆåº”æ¿€ååº”ä¿ƒè¿›è½¬ç§» [RNA-Seq OE]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288033">GSE288033 é€šè¿‡æ•´åˆåŸºå› ç»„åˆ†æå’ŒéªŒè¯å¯¹åµå·¢è¡°è€ç›¸å…³åŸºå›  NDUFS5 å’Œ UBE2L3 è¿›è¡ŒåŠŸèƒ½è§£æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287822">GSE287822 ä¸¤ç§è·å¾—æ€§ç™«ç—«å¤§é¼ æ¨¡å‹ä¸­åŸºå› è¡¨è¾¾å’Œç”²åŸºåŒ–å˜åŒ–çš„å…±æ€§ [RRBS]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281507">GSE281507 æ…¢æ€§è½»åº¦åº”æ¿€ä»¥æ€§åˆ«ä¾èµ–çš„æ–¹å¼æ”¹å˜ç»ˆçº¹å‰èƒŒä¾§æ ¸åºŠçš„è½¬å½•ç»„å’Œä¿¡å·ä¼ å¯¼ç‰¹æ€§</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE263687">GSE263687 è¡°è€é€šè¿‡æ¿€æ´»æ•´åˆåº”æ¿€ååº”ä¿ƒè¿›è½¬ç§»ï¼ˆATAC-Seqï¼‰</a></li></ul></div></details><hr><p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2026-01-23 21:39</em><br><em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p></div><footer class=post__footer><div class="post__tags tags clearfix"><svg class="tags__badge icon icon-tag" width="16" height="16" viewBox="0 0 32 32"><path d="M4 0h8s2 0 4 2l15 15s2 2 0 4L21 31s-2 2-4 0L2 16s-2-2-2-4V3s0-3 4-3m3 10a3 3 0 000-6 3 3 0 000 6"/></svg><ul class=tags__list><li class=tags__item><a class="tags__link btn" href=../../../tags/research/ rel=tag>Research</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/daily/ rel=tag>Daily</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/week042026/ rel=tag>Week042026</a></li></ul></div></footer></article></main><div class="authorbox clearfix"><div class=authorbox__header><span class=authorbox__name>About Bloger</span></div></div><nav class="pager flex"><div class="pager__item pager__item--prev"><a class=pager__link href=../../../posts/dailyreports/2026-01-23/ rel=prev><span class=pager__subtitle>Â«&#8201;Previous</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2026-01-23</p></a></div><div class="pager__item pager__item--next"><a class=pager__link href=../../../posts/dailyreports/2026-01-25/ rel=next><span class=pager__subtitle>Next&#8201;Â»</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2026-01-25</p></a></div></nav><section class=comments><div id=disqus_thread></div><script>window.disqus_config=function(){},function(){if(["localhost","127.0.0.1"].indexOf(window.location.hostname)!=-1){document.getElementById("disqus_thread").innerHTML="Disqus comments not available by default when the website is previewed locally.";return}var t=document,e=t.createElement("script");e.async=!0,e.src="//kkitown.disqus.com/embed.js",e.setAttribute("data-timestamp",+new Date),(t.head||t.body).appendChild(e)}()</script><noscript>Please enable JavaScript to view the <a href=https://disqus.com/?ref_noscript>comments powered by Disqus.</a></noscript><a href=https://disqus.com class=dsq-brlink>comments powered by <span class=logo-disqus>Disqus</span></a></section></div><aside class=sidebar><div class="widget-search widget"><form class=widget-search__form role=search method=get action=https://google.com/search><input class=widget-search__field type=search placeholder=Searchâ€¦ name=q aria-label=Searchâ€¦>
<input class=widget-search__submit type=submit value=Search>
<input type=hidden name=sitesearch value=https://ixxmu.github.io/></form></div><div class="widget-recent widget"><h4 class=widget__title>Recent Posts</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-17/>ç§‘ç ”æ—¥æŠ¥ 2026-02-17</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-16/>ç§‘ç ”æ—¥æŠ¥ 2026-02-16</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-15/>ç§‘ç ”æ—¥æŠ¥ 2026-02-15</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-14/>ç§‘ç ”æ—¥æŠ¥ 2026-02-14</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-13/>ç§‘ç ”æ—¥æŠ¥ 2026-02-13</a></li></ul></div></div><div class="widget-categories widget"><h4 class=widget__title>Categories</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../categories/dailyreport/>DailyReport</a></li><li class=widget__item><a class=widget__link href=../../../categories/learnr/>LearnR</a></li></ul></div></div><div class="widget-taglist widget"><h4 class=widget__title>Tags</h4><div class=widget__content><a class="widget-taglist__link widget__link btn" href=../../../tags/daily/ title=Daily>Daily (110)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/research/ title=Research>Research (110)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week022026/ title=Week022026>Week022026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week032026/ title=Week032026>Week032026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week042026/ title=Week042026>Week042026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week052026/ title=Week052026>Week052026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week062026/ title=Week062026>Week062026 (6)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week072026/ title=Week072026>Week072026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week452025/ title=Week452025>Week452025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week462025/ title=Week462025>Week462025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week472025/ title=Week472025>Week472025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week482025/ title=Week482025>Week482025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week492025/ title=Week492025>Week492025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week502025/ title=Week502025>Week502025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week512025/ title=Week512025>Week512025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week522025/ title=Week522025>Week522025 (7)</a></div><a href=../../../tags/></a></div><div class="widget-social widget"><h4 class="widget-social__title widget__title">Social</h4><div class="widget-social__content widget__content"><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Facebook rel="noopener noreferrer" href=https://facebook.com/username target=_blank><svg class="widget-social__link-icon icon icon-facebook" width="24" height="24" viewBox="0 0 352 352"><path d="m0 32v288c0 17.5 14.5 32 32 32h288c17.5.0 32-14.5 32-32V32c0-17.5-14.5-32-32-32H32C14.5.0.0 14.5.0 32zm320 0v288h-83V212h41.5l6-48H237v-31c0-14 3.5-23.5 23.5-23.5h26V66c-4.4-.6-19.8-1.5-37.5-1.5-36.9.0-62 22.2-62 63.5v36h-42v48h42v108H32V32z"/></svg>
<span>Facebook</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Twitter rel="noopener noreferrer" href=https://twitter.com/username target=_blank><svg class="widget-social__link-icon icon icon-twitter" width="24" height="24" viewBox="0 0 384 312"><path d="m384 36.9c-14.1 6.3-29.3 10.5-45.2 12.4 16.3-9.7 28.8-25.2 34.6-43.6-15.2 9-32.1 15.6-50 19.1-14.4-15.2-34.9-24.8-57.5-24.8-43.5.0-78.8 35.3-78.8 78.8.0 6.2.7 12.2 2 17.9-65.5-3.3-123.5-34.6-162.4-82.3C20 26 16.1 39.6 16.1 54c0 27.3 13.9 51.4 35 65.6-12.9-.4-25.1-4-35.7-9.9v1c0 38.2 27.2 70 63.2 77.2-6.6 1.8-13.6 2.8-20.8 2.8-5.1.0-10-.5-14.8-1.4 10 31.3 39.1 54.1 73.6 54.7-27 21.1-60.9 33.7-97.8 33.7-6.4.0-12.6-.4-18.8-1.1C34.9 299 76.3 312 120.8 312c144.9.0 224.1-120 224.1-224.1.0-3.4-.1-6.8-.2-10.2 15.4-11.1 28.7-25 39.3-40.8z"/></svg>
<span>Twitter</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Instagram rel="noopener noreferrer" href=https://www.instagram.com/username target=_blank><svg class="widget-social__link-icon icon icon-instagram" width="24" height="24" viewBox="0 0 256 256"><circle cx="193" cy="59" r="15"/><path fill-rule="evenodd" d="M101 0h54c41 0 58.4 3.9 74.5 17C256.2 37.5 256 74.8 256 97.7v60c0 26.7.0 60.4-26.5 81.4-16 13.4-33.5 16.9-74.5 16.9h-54c-41 0-57.5-3.5-74.5-16.9C1 218.9.5 186.3.1 160.5L0 155V97.7c0-23-.2-60.2 26.5-80.7C45 2 60 0 101 0zm4.9 23h44.3c45.8.0 58.3 3.5 70.3 17.5 11.8 13.2 12 30.1 12.5 62.9V156c.2 20.8.3 45.8-12.5 59.5-12 14-24.5 17.5-70.3 17.5h-44.3c-45.9.0-57.3-3.5-70.4-17.5-12.2-13-12.3-36.5-12.4-56.7v-55.6c.4-32.6.7-49.6 12.4-62.7C48 26.5 60 23 105.9 23zm19.6 144.5a42 42 0 100-84 42 42 0 000 84zm0 22.5a64.5 64.5.0 100-129 64.5 64.5.0 000 129z"/></svg>
<span>Instagram</span></a></div></div></div></aside></div><footer class=footer><div class="container footer__container flex"><div class=footer__copyright>&copy; 2026 ç”Ÿä¿¡æ™®æ‹‰æ–¯.
<span class=footer__copyright-credits>Generated with <a href=https://gohugo.io/ rel="nofollow noopener" target=_blank>Hugo</a> and <a href=https://github.com/Vimux/Mainroad/ rel="nofollow noopener" target=_blank>Mainroad</a> theme.</span></div></div></footer></div><script async defer src=../../../js/menu.js></script><script src=../../../js/custom.js></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.6/MathJax.js?config=TeX-AMS-MML_HTMLorMML" async></script></body></html>